CTX213 holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals) with 2 filings. The WikiTrademarks Expansion Score is 6/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed September 3, 2026
Protect or track "CTX213"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is CTX213 filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Filing Activity by NICE Class
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 99582999 | CTX213 | Jan 07, 2026 | Registered | 005 Pharmaceuticals 042 Science & Technology | CRISPR Therapeutics AG |
| 98955696 | CTX213 | Jan 13, 2025 | Pending | 005 Pharmaceuticals 042 Science & Technology | CRISPR Therapeutics AG |
Weekly visibility reports showing how ChatGPT mentions CTX213, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: CTX213 trademark portfolio
What trademarks does CTX213 hold?
CTX213 holds 2 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 5 (Pharmaceuticals), Class 42 (Science & Technology). The most recent filings are registered to CRISPR Therapeutics AG.
How many trademarks does CTX213 have at the USPTO?
WikiTrademarks tracks 2 USPTO trademark filings attributed to CTX213. The brand has been actively filing since January 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does CTX213 file most often?
CTX213's most active class is NICE Class 5 (Pharmaceuticals), with 2 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the CTX213 trademark?
The most recent filings under the CTX213 mark are registered to CRISPR Therapeutics AG. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is CTX213 expanding into new categories?
The current WikiTrademarks Expansion Score for CTX213 is 6 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new CTX213 trademark filings?
Click the Watch Brand button at the top of this page to add CTX213 to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare CTX213 to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about CTX213 and help the next person researching it.